Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleFemale and preserved platelet count subgroups of myelodysplastic syndrome patients benefit from standard‐dose azacitidine.AuthorsOgawa, Shinichi; Sakamoto, Tatsuhiro; Matsuoka, Ryota; Ishitsuka, Kantaro; Ogino, Yasuko; Sootome, Ayano; Makishima, Kenichi; Yoshida, Chikashi; Ito, Yufu; Shimizu, Seiichi; Suyama, Takuya; Shinagawa, Atsushi; Ito, Takayoshi; Obara, Naoshi; Kusakabe, Manabu; Sakata‐Yanagimoto, Mamiko; Miyazaki, Yasushi; Nannya, Yasuhito; Chiba, ShigeruPublicationCancer Reports, 2024, Vol 7, Issue 1, p1ISSN2573-8348Publication typeArticleDOI10.1002/cnr2.1938